nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—SLCO1B3—Methotrexate—ankylosing spondylitis	0.149	0.192	CbGbCtD
Atazanavir—ABCC1—Methotrexate—ankylosing spondylitis	0.103	0.133	CbGbCtD
Atazanavir—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0818	0.106	CbGbCtD
Atazanavir—ABCB1—Betamethasone—ankylosing spondylitis	0.0532	0.0687	CbGbCtD
Atazanavir—ABCB1—Prednisolone—ankylosing spondylitis	0.0524	0.0678	CbGbCtD
Atazanavir—ABCB1—Prednisone—ankylosing spondylitis	0.0495	0.064	CbGbCtD
Atazanavir—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.049	0.0633	CbGbCtD
Atazanavir—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0371	0.048	CbGbCtD
Atazanavir—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0319	0.0412	CbGbCtD
Atazanavir—CYP3A4—Betamethasone—ankylosing spondylitis	0.0318	0.0411	CbGbCtD
Atazanavir—CYP3A4—Prednisolone—ankylosing spondylitis	0.0314	0.0406	CbGbCtD
Atazanavir—ABCB1—Dexamethasone—ankylosing spondylitis	0.0309	0.0399	CbGbCtD
Atazanavir—CYP3A4—Prednisone—ankylosing spondylitis	0.0297	0.0383	CbGbCtD
Atazanavir—ABCB1—Methotrexate—ankylosing spondylitis	0.0248	0.0321	CbGbCtD
Atazanavir—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0185	0.0239	CbGbCtD
Atazanavir—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000298	0.00132	CcSEcCtD
Atazanavir—Hypertension—Triamcinolone—ankylosing spondylitis	0.000298	0.00132	CcSEcCtD
Atazanavir—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000297	0.00132	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000296	0.00131	CcSEcCtD
Atazanavir—Myalgia—Triamcinolone—ankylosing spondylitis	0.000294	0.0013	CcSEcCtD
Atazanavir—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000293	0.0013	CcSEcCtD
Atazanavir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000293	0.0013	CcSEcCtD
Atazanavir—Eye disorder—Prednisone—ankylosing spondylitis	0.000293	0.00129	CcSEcCtD
Atazanavir—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000292	0.00129	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000291	0.00129	CcSEcCtD
Atazanavir—Depression—Methotrexate—ankylosing spondylitis	0.000291	0.00129	CcSEcCtD
Atazanavir—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00029	0.00129	CcSEcCtD
Atazanavir—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00029	0.00129	CcSEcCtD
Atazanavir—Discomfort—Triamcinolone—ankylosing spondylitis	0.00029	0.00128	CcSEcCtD
Atazanavir—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00029	0.00128	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000289	0.00128	CcSEcCtD
Atazanavir—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000287	0.00127	CcSEcCtD
Atazanavir—Renal failure—Methotrexate—ankylosing spondylitis	0.000287	0.00127	CcSEcCtD
Atazanavir—Angioedema—Dexamethasone—ankylosing spondylitis	0.000286	0.00127	CcSEcCtD
Atazanavir—Angioedema—Betamethasone—ankylosing spondylitis	0.000286	0.00127	CcSEcCtD
Atazanavir—Stomatitis—Methotrexate—ankylosing spondylitis	0.000284	0.00126	CcSEcCtD
Atazanavir—Angiopathy—Prednisone—ankylosing spondylitis	0.000284	0.00126	CcSEcCtD
Atazanavir—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000283	0.00125	CcSEcCtD
Atazanavir—Immune system disorder—Prednisone—ankylosing spondylitis	0.000283	0.00125	CcSEcCtD
Atazanavir—Malaise—Dexamethasone—ankylosing spondylitis	0.000282	0.00125	CcSEcCtD
Atazanavir—Malaise—Betamethasone—ankylosing spondylitis	0.000282	0.00125	CcSEcCtD
Atazanavir—Oedema—Triamcinolone—ankylosing spondylitis	0.000282	0.00125	CcSEcCtD
Atazanavir—Syncope—Dexamethasone—ankylosing spondylitis	0.000281	0.00124	CcSEcCtD
Atazanavir—Syncope—Betamethasone—ankylosing spondylitis	0.000281	0.00124	CcSEcCtD
Atazanavir—Infection—Triamcinolone—ankylosing spondylitis	0.00028	0.00124	CcSEcCtD
Atazanavir—Sweating—Methotrexate—ankylosing spondylitis	0.000279	0.00124	CcSEcCtD
Atazanavir—Infection—Methylprednisolone—ankylosing spondylitis	0.000279	0.00123	CcSEcCtD
Atazanavir—Haematuria—Methotrexate—ankylosing spondylitis	0.000278	0.00123	CcSEcCtD
Atazanavir—Shock—Triamcinolone—ankylosing spondylitis	0.000277	0.00123	CcSEcCtD
Atazanavir—Insomnia—Prednisolone—ankylosing spondylitis	0.000277	0.00123	CcSEcCtD
Atazanavir—Alopecia—Prednisone—ankylosing spondylitis	0.000277	0.00122	CcSEcCtD
Atazanavir—Shock—Methylprednisolone—ankylosing spondylitis	0.000276	0.00122	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000276	0.00122	CcSEcCtD
Atazanavir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000275	0.00122	CcSEcCtD
Atazanavir—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000275	0.00122	CcSEcCtD
Atazanavir—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000275	0.00122	CcSEcCtD
Atazanavir—Mental disorder—Prednisone—ankylosing spondylitis	0.000274	0.00121	CcSEcCtD
Atazanavir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000273	0.00121	CcSEcCtD
Atazanavir—Malnutrition—Prednisone—ankylosing spondylitis	0.000273	0.00121	CcSEcCtD
Atazanavir—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000272	0.0012	CcSEcCtD
Atazanavir—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000272	0.0012	CcSEcCtD
Atazanavir—Convulsion—Dexamethasone—ankylosing spondylitis	0.000271	0.0012	CcSEcCtD
Atazanavir—Convulsion—Betamethasone—ankylosing spondylitis	0.000271	0.0012	CcSEcCtD
Atazanavir—Hypertension—Dexamethasone—ankylosing spondylitis	0.00027	0.0012	CcSEcCtD
Atazanavir—Hypertension—Betamethasone—ankylosing spondylitis	0.00027	0.0012	CcSEcCtD
Atazanavir—Myalgia—Betamethasone—ankylosing spondylitis	0.000266	0.00118	CcSEcCtD
Atazanavir—Myalgia—Dexamethasone—ankylosing spondylitis	0.000266	0.00118	CcSEcCtD
Atazanavir—Anxiety—Dexamethasone—ankylosing spondylitis	0.000266	0.00118	CcSEcCtD
Atazanavir—Anxiety—Betamethasone—ankylosing spondylitis	0.000266	0.00118	CcSEcCtD
Atazanavir—Discomfort—Dexamethasone—ankylosing spondylitis	0.000263	0.00117	CcSEcCtD
Atazanavir—Discomfort—Betamethasone—ankylosing spondylitis	0.000263	0.00117	CcSEcCtD
Atazanavir—Pain—Prednisolone—ankylosing spondylitis	0.000262	0.00116	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—ankylosing spondylitis	0.000262	0.00116	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000258	0.00114	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000257	0.00114	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000256	0.00114	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000256	0.00113	CcSEcCtD
Atazanavir—Oedema—Dexamethasone—ankylosing spondylitis	0.000255	0.00113	CcSEcCtD
Atazanavir—Oedema—Betamethasone—ankylosing spondylitis	0.000255	0.00113	CcSEcCtD
Atazanavir—Insomnia—Triamcinolone—ankylosing spondylitis	0.000255	0.00113	CcSEcCtD
Atazanavir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000254	0.00112	CcSEcCtD
Atazanavir—Infection—Dexamethasone—ankylosing spondylitis	0.000254	0.00112	CcSEcCtD
Atazanavir—Infection—Betamethasone—ankylosing spondylitis	0.000254	0.00112	CcSEcCtD
Atazanavir—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000253	0.00112	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000252	0.00112	CcSEcCtD
Atazanavir—Shock—Betamethasone—ankylosing spondylitis	0.000251	0.00111	CcSEcCtD
Atazanavir—Shock—Dexamethasone—ankylosing spondylitis	0.000251	0.00111	CcSEcCtD
Atazanavir—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000251	0.00111	CcSEcCtD
Atazanavir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000251	0.00111	CcSEcCtD
Atazanavir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000251	0.00111	CcSEcCtD
Atazanavir—Agitation—Prednisone—ankylosing spondylitis	0.00025	0.00111	CcSEcCtD
Atazanavir—Angioedema—Prednisone—ankylosing spondylitis	0.000249	0.0011	CcSEcCtD
Atazanavir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000248	0.0011	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000247	0.00109	CcSEcCtD
Atazanavir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000247	0.00109	CcSEcCtD
Atazanavir—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000247	0.00109	CcSEcCtD
Atazanavir—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000247	0.00109	CcSEcCtD
Atazanavir—Malaise—Prednisone—ankylosing spondylitis	0.000246	0.00109	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00108	CcSEcCtD
Atazanavir—Syncope—Prednisone—ankylosing spondylitis	0.000244	0.00108	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—ankylosing spondylitis	0.000244	0.00108	CcSEcCtD
Atazanavir—Anorexia—Dexamethasone—ankylosing spondylitis	0.000243	0.00108	CcSEcCtD
Atazanavir—Anorexia—Betamethasone—ankylosing spondylitis	0.000243	0.00108	CcSEcCtD
Atazanavir—Urticaria—Prednisolone—ankylosing spondylitis	0.000243	0.00108	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000243	0.00107	CcSEcCtD
Atazanavir—Fatigue—Triamcinolone—ankylosing spondylitis	0.000243	0.00107	CcSEcCtD
Atazanavir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000242	0.00107	CcSEcCtD
Atazanavir—Pain—Triamcinolone—ankylosing spondylitis	0.000241	0.00107	CcSEcCtD
Atazanavir—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00024	0.00106	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—ankylosing spondylitis	0.000237	0.00105	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000236	0.00105	CcSEcCtD
Atazanavir—Convulsion—Prednisone—ankylosing spondylitis	0.000236	0.00105	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000236	0.00104	CcSEcCtD
Atazanavir—Hypertension—Prednisone—ankylosing spondylitis	0.000235	0.00104	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000233	0.00103	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000233	0.00103	CcSEcCtD
Atazanavir—Arthralgia—Prednisone—ankylosing spondylitis	0.000232	0.00103	CcSEcCtD
Atazanavir—Myalgia—Prednisone—ankylosing spondylitis	0.000232	0.00103	CcSEcCtD
Atazanavir—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000232	0.00103	CcSEcCtD
Atazanavir—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000231	0.00102	CcSEcCtD
Atazanavir—Anxiety—Prednisone—ankylosing spondylitis	0.000231	0.00102	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—ankylosing spondylitis	0.000231	0.00102	CcSEcCtD
Atazanavir—Insomnia—Dexamethasone—ankylosing spondylitis	0.000231	0.00102	CcSEcCtD
Atazanavir—Insomnia—Betamethasone—ankylosing spondylitis	0.000231	0.00102	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00023	0.00102	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00023	0.00102	CcSEcCtD
Atazanavir—Discomfort—Prednisone—ankylosing spondylitis	0.000229	0.00101	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—ankylosing spondylitis	0.000229	0.00101	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—ankylosing spondylitis	0.000228	0.00101	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000226	0.000998	CcSEcCtD
Atazanavir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000225	0.000995	CcSEcCtD
Atazanavir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000225	0.000995	CcSEcCtD
Atazanavir—Urticaria—Triamcinolone—ankylosing spondylitis	0.000224	0.00099	CcSEcCtD
Atazanavir—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000223	0.000988	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000223	0.000987	CcSEcCtD
Atazanavir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000223	0.000985	CcSEcCtD
Atazanavir—Oedema—Prednisone—ankylosing spondylitis	0.000222	0.000984	CcSEcCtD
Atazanavir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000222	0.000983	CcSEcCtD
Atazanavir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000222	0.000983	CcSEcCtD
Atazanavir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000222	0.000983	CcSEcCtD
Atazanavir—Infection—Prednisone—ankylosing spondylitis	0.000221	0.000978	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000221	0.000976	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000221	0.000976	CcSEcCtD
Atazanavir—Back pain—Methotrexate—ankylosing spondylitis	0.00022	0.000975	CcSEcCtD
Atazanavir—Fatigue—Betamethasone—ankylosing spondylitis	0.00022	0.000975	CcSEcCtD
Atazanavir—Fatigue—Dexamethasone—ankylosing spondylitis	0.00022	0.000975	CcSEcCtD
Atazanavir—Shock—Prednisone—ankylosing spondylitis	0.000219	0.000969	CcSEcCtD
Atazanavir—Pain—Betamethasone—ankylosing spondylitis	0.000218	0.000967	CcSEcCtD
Atazanavir—Pain—Dexamethasone—ankylosing spondylitis	0.000218	0.000967	CcSEcCtD
Atazanavir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000218	0.000965	CcSEcCtD
Atazanavir—Skin disorder—Prednisone—ankylosing spondylitis	0.000216	0.000956	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000215	0.000952	CcSEcCtD
Atazanavir—Anorexia—Prednisone—ankylosing spondylitis	0.000212	0.000938	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000211	0.000935	CcSEcCtD
Atazanavir—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00021	0.000932	CcSEcCtD
Atazanavir—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00021	0.000932	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000209	0.000924	CcSEcCtD
Atazanavir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000209	0.000924	CcSEcCtD
Atazanavir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000207	0.000918	CcSEcCtD
Atazanavir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000207	0.000916	CcSEcCtD
Atazanavir—Malaise—Methotrexate—ankylosing spondylitis	0.000205	0.000909	CcSEcCtD
Atazanavir—Urticaria—Dexamethasone—ankylosing spondylitis	0.000203	0.000898	CcSEcCtD
Atazanavir—Urticaria—Betamethasone—ankylosing spondylitis	0.000203	0.000898	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000203	0.000897	CcSEcCtD
Atazanavir—Dizziness—Prednisolone—ankylosing spondylitis	0.000202	0.000896	CcSEcCtD
Atazanavir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000202	0.000894	CcSEcCtD
Atazanavir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000202	0.000894	CcSEcCtD
Atazanavir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000202	0.000894	CcSEcCtD
Atazanavir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000202	0.000894	CcSEcCtD
Atazanavir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000202	0.000894	CcSEcCtD
Atazanavir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000202	0.000892	CcSEcCtD
Atazanavir—Insomnia—Prednisone—ankylosing spondylitis	0.000201	0.00089	CcSEcCtD
Atazanavir—Pruritus—Triamcinolone—ankylosing spondylitis	0.000199	0.000881	CcSEcCtD
Atazanavir—Cough—Methotrexate—ankylosing spondylitis	0.000199	0.00088	CcSEcCtD
Atazanavir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000199	0.000879	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—ankylosing spondylitis	0.000197	0.000873	CcSEcCtD
Atazanavir—Dyspepsia—Prednisone—ankylosing spondylitis	0.000196	0.000867	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—ankylosing spondylitis	0.000194	0.000858	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—ankylosing spondylitis	0.000194	0.000858	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—ankylosing spondylitis	0.000194	0.000858	CcSEcCtD
Atazanavir—Decreased appetite—Prednisone—ankylosing spondylitis	0.000193	0.000856	CcSEcCtD
Atazanavir—Rash—Prednisolone—ankylosing spondylitis	0.000193	0.000854	CcSEcCtD
Atazanavir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000193	0.000853	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000193	0.000852	CcSEcCtD
Atazanavir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000192	0.000851	CcSEcCtD
Atazanavir—Fatigue—Prednisone—ankylosing spondylitis	0.000192	0.000849	CcSEcCtD
Atazanavir—Headache—Prednisolone—ankylosing spondylitis	0.000192	0.000849	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—ankylosing spondylitis	0.000192	0.000848	CcSEcCtD
Atazanavir—Constipation—Prednisone—ankylosing spondylitis	0.00019	0.000842	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—ankylosing spondylitis	0.000187	0.00083	CcSEcCtD
Atazanavir—Dizziness—Triamcinolone—ankylosing spondylitis	0.000186	0.000824	CcSEcCtD
Atazanavir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000186	0.000822	CcSEcCtD
Atazanavir—Infection—Methotrexate—ankylosing spondylitis	0.000185	0.000817	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000183	0.000811	CcSEcCtD
Atazanavir—Asthenia—Betamethasone—ankylosing spondylitis	0.000183	0.000811	CcSEcCtD
Atazanavir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000183	0.000811	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000182	0.000807	CcSEcCtD
Atazanavir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000182	0.000805	CcSEcCtD
Atazanavir—Nausea—Prednisolone—ankylosing spondylitis	0.000182	0.000805	CcSEcCtD
Atazanavir—Pruritus—Dexamethasone—ankylosing spondylitis	0.000181	0.0008	CcSEcCtD
Atazanavir—Pruritus—Betamethasone—ankylosing spondylitis	0.000181	0.0008	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—ankylosing spondylitis	0.000181	0.000799	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00018	0.000795	CcSEcCtD
Atazanavir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000179	0.000792	CcSEcCtD
Atazanavir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000179	0.00079	CcSEcCtD
Atazanavir—Rash—Triamcinolone—ankylosing spondylitis	0.000178	0.000786	CcSEcCtD
Atazanavir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000177	0.000785	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—ankylosing spondylitis	0.000177	0.000784	CcSEcCtD
Atazanavir—Rash—Methylprednisolone—ankylosing spondylitis	0.000177	0.000784	CcSEcCtD
Atazanavir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000177	0.000783	CcSEcCtD
Atazanavir—Urticaria—Prednisone—ankylosing spondylitis	0.000177	0.000782	CcSEcCtD
Atazanavir—Headache—Triamcinolone—ankylosing spondylitis	0.000176	0.000781	CcSEcCtD
Atazanavir—Headache—Methylprednisolone—ankylosing spondylitis	0.000176	0.000779	CcSEcCtD
Atazanavir—Body temperature increased—Prednisone—ankylosing spondylitis	0.000176	0.000778	CcSEcCtD
Atazanavir—Abdominal pain—Prednisone—ankylosing spondylitis	0.000176	0.000778	CcSEcCtD
Atazanavir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000175	0.000773	CcSEcCtD
Atazanavir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000175	0.000773	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000169	0.00075	CcSEcCtD
Atazanavir—Dizziness—Dexamethasone—ankylosing spondylitis	0.000169	0.000748	CcSEcCtD
Atazanavir—Dizziness—Betamethasone—ankylosing spondylitis	0.000169	0.000748	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—ankylosing spondylitis	0.000168	0.000744	CcSEcCtD
Atazanavir—Nausea—Triamcinolone—ankylosing spondylitis	0.000167	0.00074	CcSEcCtD
Atazanavir—Nausea—Methylprednisolone—ankylosing spondylitis	0.000167	0.000738	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000166	0.000734	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—ankylosing spondylitis	0.000165	0.000731	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000164	0.000725	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000164	0.000724	CcSEcCtD
Atazanavir—Vomiting—Betamethasone—ankylosing spondylitis	0.000162	0.000719	CcSEcCtD
Atazanavir—Vomiting—Dexamethasone—ankylosing spondylitis	0.000162	0.000719	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000162	0.000715	CcSEcCtD
Atazanavir—Rash—Betamethasone—ankylosing spondylitis	0.000161	0.000713	CcSEcCtD
Atazanavir—Rash—Dexamethasone—ankylosing spondylitis	0.000161	0.000713	CcSEcCtD
Atazanavir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000161	0.000712	CcSEcCtD
Atazanavir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000161	0.000712	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000161	0.00071	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—ankylosing spondylitis	0.00016	0.000709	CcSEcCtD
Atazanavir—Headache—Dexamethasone—ankylosing spondylitis	0.00016	0.000708	CcSEcCtD
Atazanavir—Headache—Betamethasone—ankylosing spondylitis	0.00016	0.000708	CcSEcCtD
Atazanavir—Asthenia—Prednisone—ankylosing spondylitis	0.00016	0.000706	CcSEcCtD
Atazanavir—Pain—Methotrexate—ankylosing spondylitis	0.000159	0.000704	CcSEcCtD
Atazanavir—Pruritus—Prednisone—ankylosing spondylitis	0.000157	0.000697	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000153	0.000678	CcSEcCtD
Atazanavir—Diarrhoea—Prednisone—ankylosing spondylitis	0.000152	0.000674	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000152	0.000673	CcSEcCtD
Atazanavir—Nausea—Betamethasone—ankylosing spondylitis	0.000152	0.000671	CcSEcCtD
Atazanavir—Nausea—Dexamethasone—ankylosing spondylitis	0.000152	0.000671	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—ankylosing spondylitis	0.000148	0.000654	CcSEcCtD
Atazanavir—Dizziness—Prednisone—ankylosing spondylitis	0.000147	0.000651	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000147	0.00065	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000147	0.00065	CcSEcCtD
Atazanavir—Vomiting—Prednisone—ankylosing spondylitis	0.000141	0.000626	CcSEcCtD
Atazanavir—Rash—Prednisone—ankylosing spondylitis	0.00014	0.000621	CcSEcCtD
Atazanavir—Dermatitis—Prednisone—ankylosing spondylitis	0.00014	0.00062	CcSEcCtD
Atazanavir—Headache—Prednisone—ankylosing spondylitis	0.000139	0.000617	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000137	0.000606	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—ankylosing spondylitis	0.000133	0.00059	CcSEcCtD
Atazanavir—Nausea—Prednisone—ankylosing spondylitis	0.000132	0.000585	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—ankylosing spondylitis	0.000132	0.000582	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000127	0.000563	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—ankylosing spondylitis	0.000123	0.000544	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—ankylosing spondylitis	0.000118	0.000523	CcSEcCtD
Atazanavir—Rash—Methotrexate—ankylosing spondylitis	0.000117	0.000519	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—ankylosing spondylitis	0.000117	0.000518	CcSEcCtD
Atazanavir—Headache—Methotrexate—ankylosing spondylitis	0.000116	0.000515	CcSEcCtD
Atazanavir—Nausea—Methotrexate—ankylosing spondylitis	0.00011	0.000489	CcSEcCtD
